Clarinase Repetabs Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Loratadine 5 mg, pseudoephedrine sulfate 120 mg

Indications/Uses

Symptomatic relief of allergic rhinitis & common cold including nasal congestion, sneezing, rhinorrhea, pruritus & lacrimation.

Click to view Clarinase Repetabs detailed prescribing information

Dosage/Direction for Use

Adult & childn ≥12 yr 1 repetab bd.

Click to view Clarinase Repetabs detailed prescribing information

Overdosage

View Clarinase Repetabs overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Swallow whole, do not chew/crush.

Contraindications

Hypersensitivity to loratadine, pseudoephedrine sulfate, adrenergic agents or other drugs of similar chemical structure. Narrow-angle glaucoma, urinary retention, severe HTN & CAD, hyperthyroidism. Patients receiving MAOI therapy or w/in 14 days of discontinuation.

Click to view Clarinase Repetabs detailed prescribing information

Special Precautions

Glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, prostatic hypertrophy or bladder neck obstruction, CV disease, increased IOP, DM; CNS stimulation, excitability, convulsions &/or CV collapse w/ accompanying hypotension. Discontinue use approx 48 hr prior to skin testing. Avoid abrupt w/drawal. Concomitant use w/ digitalis. Severe hepatic impairment. Pregnancy & lactation. Childn <12 yr. Elderly ≥ 60 yr.

Click to view Clarinase Repetabs detailed prescribing information

Use In Pregnancy & Lactation

Click to view Clarinase Repetabs detailed prescribing information

Adverse Reactions

Insomnia, dry mouth, headache, somnolence.

Click to view Clarinase Repetabs detailed prescribing information

Drug Interactions

Increased plasma conc w/ ketoconazole, erythromycin, cimetidine. Hypertensive reactions including hypertensive crisis w/ MAOIs. Reduced antihypertensive effects of methyldopa, mecamylamine, reserpine, veratrum alkaloids. Increased ectopic pacemaker activity w/ digitalis. Increased absorption rate by antacids. Decreased absorption rate by kaolin. Diminished +ve reactions to dermal reactivity indicators. Concomitant use w/ β-blockers; other drugs inhibiting hepatic metabolism.

Click to view Clarinase Repetabs detailed prescribing information

Description

View Clarinase Repetabs description for details of the chemical structure and excipients (inactive components).

Action

View Clarinase Repetabs mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cough & Cold Preparations / Antihistamines & Antiallergics

ATC Classification

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.

Regulatory Classification

Presentation/Packing

Form

Clarinase Repetabs

Packing/Price

5 × 10's

Clarinase Repetabs

loratadine + pseudoephedrine

Manufacturer:

Bayer

Distributor:

Zuellig Pharma